We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

IMMCO DIAGNOSTICS, INC.

Immco Diagnostics is licensed throughout the US for testing serology, biopsy and genetic specimens. Their lab special... read more Featured Products: More products

Download Mobile App




Breakthrough Blood Test Available to Detect Sjögren’s Syndrome

By LabMedica International staff writers
Posted on 10 Mar 2015
A test has been developed that more accurately identifies a diagnosis of Sjögren’s Syndrome early in the process, thus ultimately improving identification and treatment of the devastating autoimmune illness. More...


Sjögren’s Syndrome (SS) is a chronic autoimmune disease and those suffering from the condition experience painfully dry eyes and mouth caused from the body’s own cells attacking moisture producing glands. Both genetic factors and non-genetic factors are at play when it comes to the development of the slowly progressive disease.

Immunologists at the State University of New York (Buffalo, NY, USA) working with Immco Diagnostics, Inc. (Buffalo, NY, USA) developed a new diagnostic test that would be used to precisely detect the presence anti-salivary gland protein 1 (SP1) antibodies that have recently been identified in patients with SS.

A recent study revealed that anti-SP1 antibodies were present in the sera of 52% of SS patients while anti-Ro/anti-La was present in 63% of patients. 19% of patients had anti-SP1 without anti-Ro/anti-La. Patients with SS and lymphoma expressed anti-Ro, anti-La, and anti-SP1 together. In SS associated with rheumatoid arthritis, 50% had antibodies anti-SP1 while 40% had anti-Ro/anti-La. In conclusion, anti-SP1 antibodies are commonly seen in both primary and secondary SS and rarely in normal controls.

Prior to the development of Immco Diagnostics’ Sjö blood test, the diagnosis of Sjögren’s Syndrome was considered to be very difficult, often taking an average of 3.9 years from the first signs of symptoms. The novel biomarkers have significantly higher sensitivity and specificity than with traditional screening methods, making them more likely to detect early signs of the disease.

Susan Baker MD, a board certified in both internal medicine and rheumatology, said, “As a rheumatologist, I am very enthused to learn that a new blood test will have the capability to distinguish Sjögren’s Syndrome from other diseases with very similar symptoms. Early detection and having a treatment plan in place for those living with the harsh reality of this disease will prevent more serious complications from occurring down the road. I am hopeful that this will improve patient outcomes.”

Related Links:

State University of New York at Buffalo
Immco Diagnostics, Inc. 



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.